Abstract |
Potocki-Lupski Syndrome (PTLS, MIM 610883), or duplication of chromosome 17p11.2, is a clinically recognizable condition characterized by infantile hypotonia, failure to thrive, developmental delay, intellectual disability, and congenital anomalies. Short stature, classified as greater than two standard deviations below the mean, has not previously been considered a major feature of PTLS. Retrospective chart review on a cohort of 37 individuals with PTLS was performed to investigate the etiology of short stature. Relevant data included anthropometric measurements, insulin growth factor-1 (IGF-1), insulin-like growth factor binding protein 3 (IGFBP-3), growth hormone (GH) stimulation testing, blood glucose levels, brain MRI, and bone age. Approximately 25% (9/37) of individuals with PTLS had short stature. Growth hormone deficiency (GHD) was definitively identified in two individuals. These two PTLS patients with growth hormone deficiency, as well as three others with short stature and no documented GHD, received growth hormone and obtained improvement in linear growth. One individual was identified to have pituitary abnormalities on MRI and had complications of hypoglycemia due to unrecognized GHD. Individuals with PTLS can benefit from undergoing evaluation for GHD should they present with short stature or hypoglycemia. Early identification of GHD could facilitate potential therapeutic benefit for individuals with PTLS, including linear growth, musculoskeletal, and in cases of hypoglycemia, potentially cognitive development as well.
|
Authors | Rachel Franciskovich, Claudia Soler-Alfonso, Juanita Neira-Fresneda, James R Lupski, Bonnie McCann-Crosby, Lorraine Potocki |
Journal | American journal of medical genetics. Part A
(Am J Med Genet A)
Vol. 182
Issue 9
Pg. 2077-2084
(09 2020)
ISSN: 1552-4833 [Electronic] United States |
PMID | 32656927
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Copyright | © 2020 Wiley Periodicals LLC. |
Chemical References |
- Blood Glucose
- IGFBP3 protein, human
- Insulin-Like Growth Factor Binding Protein 3
- Human Growth Hormone
- Insulin-Like Growth Factor I
|
Topics |
- Abnormalities, Multiple
(diagnostic imaging, epidemiology, genetics, pathology)
- Adolescent
- Adult
- Blood Glucose
(genetics)
- Brain
(diagnostic imaging, pathology)
- Child
- Child, Preschool
- Chromosome Disorders
(diagnostic imaging, epidemiology, genetics, pathology)
- Chromosome Duplication
(genetics)
- Comparative Genomic Hybridization
- Dwarfism, Pituitary
(diagnostic imaging, epidemiology, genetics, pathology)
- Failure to Thrive
(epidemiology, genetics, pathology)
- Female
- Human Growth Hormone
(deficiency, genetics)
- Humans
- Infant
- Insulin-Like Growth Factor Binding Protein 3
(genetics)
- Insulin-Like Growth Factor I
(genetics)
- Magnetic Resonance Imaging
- Male
- Phenotype
- Smith-Magenis Syndrome
(diagnostic imaging, epidemiology, genetics, pathology)
- Young Adult
|